SLNO logo

Soleno Therapeutics (SLNO) Operating expenses

annual operating expenses:

$184.43M+$145.76M(+376.93%)
December 31, 2024

Summary

  • As of today (July 1, 2025), SLNO annual total operating expenses is $184.43 million, with the most recent change of +$145.76 million (+376.93%) on December 31, 2024.
  • During the last 3 years, SLNO annual operating expenses has risen by +$152.17 million (+471.71%).
  • SLNO annual operating expenses is now at all-time high.

Performance

SLNO Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLNOincome statement metrics

quarterly operating expenses:

$42.78M-$16.01M(-27.24%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SLNO quarterly total operating expenses is $42.78 million, with the most recent change of -$16.01 million (-27.24%) on March 31, 2025.
  • Over the past year, SLNO quarterly operating expenses has increased by +$19.70 million (+85.39%).
  • SLNO quarterly operating expenses is now -46.08% below its all-time high of $79.33 million, reached on September 30, 2024.

Performance

SLNO quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLNOincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

SLNO Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+376.9%+85.4%
3 y3 years+471.7%+545.1%
5 y5 years+695.1%+391.8%

SLNO Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+634.5%-46.1%+600.9%
5 y5-yearat high+695.1%-46.1%+600.9%
alltimeall timeat high+5027.2%-46.1%+7541.3%

SLNO Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$42.78M(-27.2%)
Dec 2024
$184.43M(+376.9%)
$58.79M(-25.9%)
Sep 2024
-
$79.33M(+241.5%)
Jun 2024
-
$23.23M(+0.7%)
Mar 2024
-
$23.07M(+79.9%)
Dec 2023
$38.67M(+54.0%)
$12.83M(+37.0%)
Sep 2023
-
$9.36M(+12.6%)
Jun 2023
-
$8.31M(+1.7%)
Mar 2023
-
$8.17M(+31.5%)
Dec 2022
$25.11M(-22.2%)
$6.21M(+1.8%)
Sep 2022
-
$6.10M(-1.0%)
Jun 2022
-
$6.16M(-7.1%)
Mar 2022
-
$6.63M(+4.8%)
Dec 2021
$32.26M(+1.0%)
$6.33M(-18.2%)
Sep 2021
-
$7.74M(-3.9%)
Jun 2021
-
$8.05M(-20.6%)
Mar 2021
-
$10.14M(+29.8%)
Dec 2020
$31.95M(+37.7%)
$7.82M(+10.4%)
Sep 2020
-
$7.08M(-15.2%)
Jun 2020
-
$8.35M(-4.0%)
Mar 2020
-
$8.70M(+26.4%)
Dec 2019
$23.20M(+68.9%)
$6.88M(+12.7%)
Sep 2019
-
$6.11M(+12.2%)
Jun 2019
-
$5.44M(+14.0%)
Mar 2019
-
$4.77M(+34.2%)
DateAnnualQuarterly
Dec 2018
$13.73M(+41.9%)
$3.56M(-2.5%)
Sep 2018
-
$3.65M(+4.9%)
Jun 2018
-
$3.48M(+14.2%)
Mar 2018
-
$3.05M(+12.6%)
Dec 2017
$9.68M(+16.3%)
$2.71M(+2.9%)
Sep 2017
-
$2.63M(-11.4%)
Jun 2017
-
$2.97M(+116.2%)
Mar 2017
-
$1.37M(-25.1%)
Dec 2016
$8.32M(-31.7%)
$1.83M(-6.9%)
Sep 2016
-
$1.97M(-12.4%)
Jun 2016
-
$2.25M(-47.1%)
Mar 2016
-
$4.25M(+21.7%)
Dec 2015
$12.19M(+136.3%)
$3.49M(+8.5%)
Sep 2015
-
$3.22M(+3.2%)
Jun 2015
-
$3.12M(+28.4%)
Mar 2015
-
$2.43M(+31.7%)
Dec 2014
$5.16M(+34.1%)
$1.85M(+39.5%)
Sep 2014
-
$1.32M(+1.2%)
Jun 2014
-
$1.31M(+91.1%)
Mar 2014
-
$684.00K(+22.2%)
Dec 2013
$3.85M(+6.9%)
$559.80K(-43.6%)
Sep 2013
-
$993.00K(-15.6%)
Jun 2013
-
$1.18M(+5.1%)
Mar 2013
-
$1.12M
Dec 2012
$3.60M
-

FAQ

  • What is Soleno Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Soleno Therapeutics?
  • What is Soleno Therapeutics annual operating expenses year-on-year change?
  • What is Soleno Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Soleno Therapeutics?
  • What is Soleno Therapeutics quarterly operating expenses year-on-year change?

What is Soleno Therapeutics annual total operating expenses?

The current annual operating expenses of SLNO is $184.43M

What is the all time high annual operating expenses for Soleno Therapeutics?

Soleno Therapeutics all-time high annual total operating expenses is $184.43M

What is Soleno Therapeutics annual operating expenses year-on-year change?

Over the past year, SLNO annual total operating expenses has changed by +$145.76M (+376.93%)

What is Soleno Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of SLNO is $42.78M

What is the all time high quarterly operating expenses for Soleno Therapeutics?

Soleno Therapeutics all-time high quarterly total operating expenses is $79.33M

What is Soleno Therapeutics quarterly operating expenses year-on-year change?

Over the past year, SLNO quarterly total operating expenses has changed by +$19.70M (+85.39%)
On this page